Arrivederci Milano, hallo Amsterdam!

Faculty

• Aleksander Krag (Moderator)
• Debbie Shawcross (Moderator)
• Cyrielle Caussy (Faculty)
• Ana Lleo (Faculty)
• Francesco Negro (Faculty)
• Vlad Ratziu (Faculty)
• Virginia Hernández-Gea (Faculty)

All EASL Studio Podcasts are available on EASL Campus.

EASL Studio - Education at the heart of EASL’s mission

Faculty

• Sven Francque (Moderator)
• Krista Rombouts (Faculty)
• Rajeshwar Mookerjee (Faculty)
• Henning Grønbæk (Faculty)

All EASL Studio Podcasts are available on EASL Campus.

EASL Studio - Landmark studies at the EASL Congress 2024

Faculty

• Thomas Berg (Moderator)
• Rajiv Jalan (Faculty)
• Verena Keitel (Faculty)
• Frank Tacke (Faculty)

All EASL Studio Podcasts are available on EASL Campus.

EASL Studio - SLD nomenclature: Need for refinement?

Faculty

• Aleksander Krag (Moderator)
• Meena Bansal (Faculty)
• Sven Francque (Faculty)
• Alexandre Louvet (Faculty)

All EASL Studio Podcasts are available on EASL Campus.

EASL Studio - Exploring new frontiers: The AI liver taskforce initiative

Faculty

• Eric Trépo (Moderator)
• Tom Lüdde (Faculty)
• Jakob Kather (Faculty)
• Raquel Pérez-López (Faculty)

All EASL Studio Podcasts are available on EASL Campus.

EASL Studio - Advances in systemic treatments in liver cancer

Faculty

• Josep Llovet (Moderator)
• Massimo Iavarone (Faculty)
• Matthias Pinter (Faculty)
• Jessica Zucman-Rossi (Faculty)

All EASL Studio Podcasts are available on EASL Campus.

EASL Studio - Buongiorno Milano: What not to miss during EASL Congress.

Faculty

• Aleksander Krag (Moderator)
• Debbie Shawcross (Faculty)
• Thomas Berg (Faculty)
• Ahmed Elsharkawy (Faculty)

All EASL Studio Podcasts are available on EASL Campus.

This session covers a wide range of topics relevant to the current landscape of viral hepatitis, including elimination efforts, resistance to direct-acting antivirals (DAAs), surveillance methods during and after therapy. This talk provides you with valuable insights through an up-to-date overview of the latest developments and challenges in the field.

Faculty

• Thomas Berg (Moderator)
• Jordan Feld (Faculty)
• Norah Terrault (Faculty)
• Heiner Wedemeyer (Faculty)

This episode is scheduled in honour of the United States’ Viral Hepatitis Awareness Month.

This EASL Studio is supported by GSK and Vir Biotechnology. EASL has received no input from GSK or Vir Biotechnology with regards to the content of this programme.

Related episodes

• Season 6, Episode 2: Why do we need HBV functional cure?
• Season 5, Episode 8: JHEP Live: Hepatitis Delta’s Latest Debate: Updates Straight from EASL’s Slate
• Season 5, Episode 3: Zoonotic Hepatitis E: What’s hot in 2023?
• EASL Studio at the EASL Congress 2023: The bumpy road of Hepatitis B drug development successes and challenges
• Season 4, Episode 19: HDV: The devil becomes treatable
• Season 4, Episode 1: Hepatitis B elimination: how far behind are we and what do we need to change to achieve it?

All EASL Studio Podcasts are available on EASL Campus.